The consistency across dose groups is telling
Results do not predict your response to any specific medication
GLP-1 agonists, such as liraglutide and semaglutide, are increasingly used in medical weight loss due to their ability to mimic the natural hormone glucagon-like peptide-1, which is, for the most part, responsible for regulating appetite and food intake
The study showed the validity of quantification of hunger, satiety, and prospective food consumption measured by VAS as well as measurement of ad libitum energy consumption and showed that the appetite recordings during the breakfast meal predicted the energy intake during the lunch meal [3]
This not only lowers your metabolic rate but affects strength and endurance as well
Why medical supervision matters in weight loss is also discussed in our article on medical weight loss programs for obesity